Driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

22
Oct

22. October 2024 to 25. October 2024 — Register here

World Orphan Drug Congress Europe 2024

The World Orphan Drug Congress Europe is the largest and most established orphan drug & rare disease event worldwide. Meet over 2000 attendees, hear from 250 leading speakers, and connect with 130 exhibitors as we bring together experts from the start-to-finish of orphan drugs. From… read more

5
Mar

5. March 2025 to 6. March 2025 — Register here

World EPA Congress 2025

The World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s. Join in Amsterdam for 2025! See here the agenda and speakers.

Our Events Section

News & Updates

Building a Competitive and Attractive Pharmaceutical Ecosystem in the EU

On Tuesday 24 September, Alexander Natz, Secretary General of the European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE), sent a letter to the President of the European Commission Ursula von der Leyen, President of the European Parliament Roberta Metsola, and President of the European Council Charles Michel,… read more

EVENT RECAP – Life Science Lectures – Episode eight – “The European Health Data Space (EHDS): your journey from regulation to implementation’’

On 2 September, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the eighth episode of its Life Science Lectures webinar series. The focus of the webinar, titled: ‘‘Implementing the European Health Data Space’’ was to delve into the implications of the secondary use of… read more

EUCOPE Member Spotlight: Q&A with EVERSANA

Every month, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. This September, we spoke with Mike Ryan, Manager, Europe, EVERSANA. Mike Ryan has worked across the life sciences and… read more

EUCOPE congratulates Ursula von der Leyen on her second mandate as President of the European Commission

EUCOPE congratulates Ursula von der Leyen on the confirmation of her second term as President of the European Commission. Her leadership and commitment to public health have been instrumental in steering Europe through challenging times. It is now fundamental to build on these accomplishments, delivering… read more

7 new members join EUCOPE network in June 2024

The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of 7 new members at its quarterly Members Meeting on 18 June 2024, following Board approval. The new members joining the EUCOPE network are Acadia, Edelman Global Advisory, Elevate Bio, GE Healthcare, Regeneron, Rhythm Pharmaceuticals and… read more

EUCOPE commends the Council Conclusions on the Future of the European Health Union, supporting a strong environment for pharmaceutical innovation

At the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) meeting on 21 June, Health Ministers adopted Council Conclusions on the Future of the European Health Union. Presenting the Council’s perspective on the forthcoming EU health agenda, the Conclusions outline strategic priorities and actions… read more

EUCOPE Congratulates Newly Elected MEPs, Looks Forward to Collaborative Efforts in Advancing a Globally Competitive EU Healthcare Ecosystem

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) extends its heartfelt congratulations to the newly elected Members of the European Parliament (MEPs). As the key representative body for predominantly small and medium-sized innovative pharmaceutical companies in Europe, EUCOPE recognises the pivotal role MEPs play in shaping… read more

EU Regulation on Substances of Human Origin officially adopted

The Regulation on Substances of Human Origin (SoHO) has been officially adopted by the EU Institutions, following the European Parliament’s approval on 24 April and the formal adoption by the Council of the European Union on 27 May. The new Regulation aims to improve the… read more

European Stakeholders call on the EU to deliver on the ambitions of Europe’s Beating Cancer Plan by increasing access to genomic testing

In June 2024, the Cancer Patients Europe, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European Society of Pathology and Lung Cancer Europe (LuCE) published a joint statement on increasing access to genomic testing, delivering on the ambitions of Europe’s Beating Cancer Plan. Over the past 10 years,… read more

EUCOPE signs EURORDIS Open Letter #ActRare2024 at ECRD 2024

On 16 May 2024, EUCOPE signed EURORDIS Open Letter #ActRare2024, during the Closing Plenary session of the 12th European Conference on Rare Diseases and Orphan Products (ECRD), organised in Brussels on 15-16 May 2024. The Open Letter is a result of, and informed by, the… read more

... or browse news by Tag

Patients Rare Disease Medicines Regulatory Health innovation Access Members Research COVID19 Events Commission ATMPs Medical Devices podcast HTA OMP EMA Digital IVDR Job Posting Brexit EHDS genomics AdvancedDxs European Commission MDR European Parliament SoHO Regulation data act Safety HERA biotech EU Health Supply MEDTECH PharmaPackage GDPR pharma competitiveness EPSCO Joint Statement EU Institutions Genomic Testing EU Beating Cancer Plan

Our News Section

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership